Ultralife financials
$6.38+5.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '23 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.9M | $47.4M | $48.5M | $43.4M | $48.6M | $50.7M | $43.9M | $35.7M | $43.0M | $31.9M | $44.5M | $39.5M |
| Gross profit | $13.9M | $10.1M | $12.1M | $9.6M | $11.6M | $12.7M | $10.6M | $8.7M | $11.6M | $7.4M | $11.4M | $9.8M |
| Gross margin | 28.9% | 21.3% | 24.9% | 22.2% | 23.9% | 25.1% | 24.2% | 24.3% | 26.9% | 23.3% | 25.6% | 24.8% |
| Operating income | $3.4M | -$215.0K | -$10.6M | -$951.0K | $2.3M | $3.4M | $1.5M | $511.0K | $3.9M | $26.0K | $3.6M | $2.1M |
| Net income | $2.5M | -$451.0K | -$7.4M | -$1.2M | $879.0K | $1.9M | $194.0K | $258.0K | $3.0M | -$346.0K | $2.9M | $1.3M |
| Net margin | 5.3% | −1.0% | −15.3% | −2.8% | 1.8% | 3.7% | 0.4% | 0.7% | 6.9% | −1.1% | 6.4% | 3.4% |
| Diluted EPS | $0.15 | $-0.03 | $-0.45 | $-0.07 | $0.05 | $0.11 | $0.01 | $0.02 | $0.18 | $-0.02 | $0.18 | $0.08 |
| EBITDA | $4.8M | $1.1M | $2.9M | $468.0K | $3.7M | $4.8M | $2.7M | $1.5M | $4.9M | $997.0K | $4.6M | $3.1M |
| Operating cash flow | $1.2M | $2.3M | $1.5M | $198.0K | $5.9M | $3.4M | $3.0M | $4.7M | $8.9M | -$81.0K | $2.4M | -$889.0K |
| Free cash flow | $735.0K | $1.5M | $607.0K | -$797.0K | $4.8M | $2.5M | $2.4M | $4.2M | $8.6M | -$453.0K | $1.4M | -$1.4M |
| Diluted shares | 16.7M | 16.7M | 16.6M | 16.6M | 16.7M | 16.7M | 16.9M | 16.9M | 16.8M | 16.1M | 16.3M | 16.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.7M | $8.9M | $9.3M | $9.3M | $10.9M | $8.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $44.6M | $47.6M | $49.7M | $50.3M | $50.9M | $53.6M |
| Total assets | $216.2M | $220.6M | $216.9M | $222.2M | $221.0M | $223.8M |
| Total liabilities | $83.6M | $90.9M | $86.8M | $84.8M | $82.3M | $87.1M |
| Shareholders' equity | $132.6M | $129.7M | $130.1M | $137.4M | $138.6M | $136.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology